154 related articles for article (PubMed ID: 10485504)
1. Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomized, multicenter, double-masked trial.
Dobrilla G; Piazzi L; Fiocca R
Clin Ther; 1999 Aug; 21(8):1321-32. PubMed ID: 10485504
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
3. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
Avner DL; Dorsch ER; Jennings DE; Greski-Rose PA
Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
[TBL] [Abstract][Full Text] [Related]
4. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
5. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse.
Bardhan KD; Crowe J; Thompson RP; Trewby PN; Keeling PN; Weir D; Crouch SL
Aliment Pharmacol Ther; 1999 Jun; 13(6):827-32. PubMed ID: 10383514
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
8. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan.
Chang FY; Chiang CY; Tam TN; Ng WW; Lee SD
J Gastroenterol Hepatol; 1995; 10(5):595-601. PubMed ID: 8963037
[TBL] [Abstract][Full Text] [Related]
10. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
[TBL] [Abstract][Full Text] [Related]
11. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
[TBL] [Abstract][Full Text] [Related]
12. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
14. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.
Ekström P; Carling L; Unge P; Anker-Hansen O; Sjöstedt S; Sellström H
Scand J Gastroenterol; 1995 Mar; 30(3):210-5. PubMed ID: 7770708
[TBL] [Abstract][Full Text] [Related]
17. Effect of lansoprazole on peptic ulcers.
Ohashi T; Sakata J; Haraguchi Y; Eto T
J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
[TBL] [Abstract][Full Text] [Related]
18. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
19. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
20. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Wong BC; Lam SK; Lai KC; Hu WH; Ching CK; Ho J; Yuen ST; Chan CK; Lau GK; Lai CL
Aliment Pharmacol Ther; 1999 Mar; 13(3):303-9. PubMed ID: 10102962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
